| 0 |
PRODUCT PROCESS CONTROL ISSUE |
1 |
0.0833 |
| 1 |
TRANSURETHRAL RESECTION SYNDROME |
1 |
0.0400 |
| 2 |
IATROGENIC INFECTION |
1 |
0.0122 |
| 3 |
PRODUCT STERILITY LACKING |
1 |
0.0119 |
| 4 |
CSF CULTURE POSITIVE |
1 |
0.0094 |
| 5 |
PROPIONIBACTERIUM INFECTION |
1 |
0.0093 |
| 6 |
DIALYSIS RELATED COMPLICATION |
3 |
0.0085 |
| 7 |
HAEMODIALYSIS COMPLICATION |
1 |
0.0059 |
| 8 |
EXPOSURE VIA INHALATION |
1 |
0.0046 |
| 9 |
SKULL FRACTURED BASE |
1 |
0.0040 |
| 10 |
ANTITHROMBIN III DECREASED |
1 |
0.0037 |
| 11 |
HYPOPROTHROMBINAEMIA |
1 |
0.0033 |
| 12 |
PRODUCT RECONSTITUTION ISSUE |
1 |
0.0032 |
| 13 |
RETROPERITONEAL ABSCESS |
1 |
0.0032 |
| 14 |
TYMPANIC MEMBRANE DISORDER |
1 |
0.0031 |
| 15 |
OSMOTIC DEMYELINATION SYNDROME |
2 |
0.0027 |
| 16 |
PRODUCT BARCODE ISSUE |
1 |
0.0026 |
| 17 |
PULSE PRESSURE DECREASED |
1 |
0.0020 |
| 18 |
ACIDOSIS HYPERCHLORAEMIC |
1 |
0.0017 |
| 19 |
LEFT ATRIAL DILATATION |
2 |
0.0016 |
| 20 |
PERITONEAL DISORDER |
1 |
0.0015 |
| 21 |
PRODUCT LOT NUMBER ISSUE |
3 |
0.0014 |
| 22 |
PSEUDOMONAS TEST POSITIVE |
1 |
0.0012 |
| 23 |
CARDIAC STRESS TEST ABNORMAL |
1 |
0.0012 |
| 24 |
COLONIC ABSCESS |
1 |
0.0012 |
| 25 |
ULNA FRACTURE |
1 |
0.0010 |
| 26 |
SYSTOLIC DYSFUNCTION |
1 |
0.0009 |
| 27 |
PRODUCT CONTAMINATION MICROBIAL |
1 |
0.0008 |
| 28 |
BRONCHIAL SECRETION RETENTION |
1 |
0.0008 |
| 29 |
PRODUCT EXPIRATION DATE ISSUE |
1 |
0.0007 |
| 30 |
BLADDER TRANSITIONAL CELL CARCINOMA |
1 |
0.0007 |
| 31 |
PRODUCT MONITORING ERROR |
1 |
0.0007 |
| 32 |
GASTROINTESTINAL WALL THICKENING |
1 |
0.0007 |
| 33 |
HAEMORRHAGIC TRANSFORMATION STROKE |
1 |
0.0007 |
| 34 |
PARAINFLUENZAE VIRUS INFECTION |
1 |
0.0007 |
| 35 |
TRANSCRIPTION MEDICATION ERROR |
1 |
0.0006 |
| 36 |
HYPERNATRAEMIA |
3 |
0.0006 |
| 37 |
MALIGNANT PLEURAL EFFUSION |
1 |
0.0006 |
| 38 |
GLIOBLASTOMA |
1 |
0.0006 |
| 39 |
PUPIL FIXED |
1 |
0.0006 |
| 40 |
PRODUCT CONTAINER SEAL ISSUE |
1 |
0.0006 |
| 41 |
PNEUMOPERITONEUM |
1 |
0.0005 |
| 42 |
PULSELESS ELECTRICAL ACTIVITY |
2 |
0.0005 |
| 43 |
RADIUS FRACTURE |
1 |
0.0004 |
| 44 |
RENAL CELL CARCINOMA |
2 |
0.0004 |
| 45 |
PRODUCT CONTAMINATION PHYSICAL |
1 |
0.0004 |
| 46 |
HAEMODIALYSIS |
3 |
0.0004 |
| 47 |
ACUTE PULMONARY OEDEMA |
2 |
0.0004 |
| 48 |
HYPERVENTILATION |
2 |
0.0003 |
| 49 |
ABORTION |
1 |
0.0003 |
| 50 |
MYELOFIBROSIS |
1 |
0.0003 |
| 51 |
OLIGURIA |
2 |
0.0003 |
| 52 |
ABDOMINAL ADHESIONS |
1 |
0.0003 |
| 53 |
BACTERIAL SEPSIS |
1 |
0.0003 |
| 54 |
ELECTROCARDIOGRAM ST SEGMENT ELEVATION |
1 |
0.0003 |
| 55 |
SUDDEN CARDIAC DEATH |
1 |
0.0003 |
| 56 |
PRODUCT CONTAMINATION |
1 |
0.0003 |
| 57 |
VENTRICULAR ARRHYTHMIA |
1 |
0.0003 |
| 58 |
UNRESPONSIVE TO STIMULI |
7 |
0.0003 |
| 59 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
1 |
0.0003 |
| 60 |
HAEMOLYSIS |
2 |
0.0003 |
| 61 |
APNOEA |
2 |
0.0003 |
| 62 |
CARDIOPULMONARY FAILURE |
1 |
0.0003 |
| 63 |
CEREBRAL ATROPHY |
1 |
0.0003 |
| 64 |
CYSTITIS HAEMORRHAGIC |
1 |
0.0002 |
| 65 |
GASTROINTESTINAL PERFORATION |
1 |
0.0002 |
| 66 |
LEFT VENTRICULAR HYPERTROPHY |
1 |
0.0002 |
| 67 |
OCULAR ICTERUS |
1 |
0.0002 |
| 68 |
WRONG DRUG ADMINISTERED |
2 |
0.0002 |
| 69 |
ILEUS PARALYTIC |
1 |
0.0002 |
| 70 |
INTERCEPTED MEDICATION ERROR |
1 |
0.0002 |
| 71 |
VIRAL UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0002 |
| 72 |
PULSE ABSENT |
1 |
0.0002 |
| 73 |
HYPERAMMONAEMIA |
1 |
0.0002 |
| 74 |
KLEBSIELLA INFECTION |
1 |
0.0002 |
| 75 |
BLOOD LACTIC ACID INCREASED |
1 |
0.0002 |
| 76 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
1 |
0.0002 |
| 77 |
STREPTOCOCCAL INFECTION |
1 |
0.0002 |
| 78 |
INTRACRANIAL PRESSURE INCREASED |
1 |
0.0002 |
| 79 |
STATUS EPILEPTICUS |
2 |
0.0002 |
| 80 |
PRODUCT LABEL CONFUSION |
1 |
0.0002 |
| 81 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
6 |
0.0002 |
| 82 |
BRAIN OEDEMA |
2 |
0.0002 |
| 83 |
OCCUPATIONAL EXPOSURE TO PRODUCT |
1 |
0.0002 |
| 84 |
INCOHERENT |
1 |
0.0002 |
| 85 |
POOR QUALITY DRUG ADMINISTERED |
1 |
0.0002 |
| 86 |
REFUSAL OF TREATMENT BY PATIENT |
1 |
0.0002 |
| 87 |
MENINGITIS |
1 |
0.0001 |
| 88 |
LEFT VENTRICULAR DYSFUNCTION |
1 |
0.0001 |
| 89 |
WRONG PRODUCT ADMINISTERED |
1 |
0.0001 |
| 90 |
CARDIO-RESPIRATORY ARREST |
6 |
0.0001 |
| 91 |
EXTRASYSTOLES |
1 |
0.0001 |
| 92 |
SUBDURAL HAEMATOMA |
2 |
0.0001 |
| 93 |
LIQUID PRODUCT PHYSICAL ISSUE |
1 |
0.0001 |
| 94 |
MEDICAL DEVICE COMPLICATION |
1 |
0.0001 |
| 95 |
DRUG DISPENSING ERROR |
2 |
0.0001 |
| 96 |
LIPASE INCREASED |
1 |
0.0001 |
| 97 |
DEVICE RELATED INFECTION |
2 |
0.0001 |
| 98 |
NASAL DISCOMFORT |
1 |
0.0001 |
| 99 |
BLOOD ALBUMIN DECREASED |
1 |
0.0001 |
| 100 |
CARDIOVASCULAR DISORDER |
3 |
0.0001 |
| 101 |
PRODUCT CONTAINER ISSUE |
1 |
0.0001 |
| 102 |
CARDIAC OPERATION |
1 |
0.0001 |
| 103 |
HAEMOLYTIC ANAEMIA |
1 |
0.0001 |
| 104 |
NEPHROPATHY |
1 |
0.0001 |
| 105 |
SUPRAVENTRICULAR TACHYCARDIA |
1 |
0.0001 |
| 106 |
SINUS BRADYCARDIA |
1 |
0.0001 |
| 107 |
BONE MARROW FAILURE |
2 |
0.0001 |
| 108 |
TEMPERATURE INTOLERANCE |
1 |
0.0001 |
| 109 |
PRODUCT ODOUR ABNORMAL |
1 |
0.0001 |
| 110 |
TRANSFUSION |
1 |
0.0001 |
| 111 |
ALTERED STATE OF CONSCIOUSNESS |
2 |
0.0001 |
| 112 |
PRODUCT DISPENSING ERROR |
2 |
0.0001 |
| 113 |
TOOTH FRACTURE |
1 |
0.0001 |
| 114 |
FISTULA |
1 |
0.0001 |
| 115 |
MITRAL VALVE INCOMPETENCE |
1 |
0.0001 |
| 116 |
MYOCARDIAL ISCHAEMIA |
1 |
0.0001 |
| 117 |
INJECTION SITE EXTRAVASATION |
1 |
0.0001 |
| 118 |
GENERALISED OEDEMA |
1 |
0.0001 |
| 119 |
INFUSION SITE PAIN |
1 |
0.0001 |
| 120 |
INJECTION SITE INDURATION |
1 |
0.0001 |
| 121 |
MENTAL STATUS CHANGES |
2 |
0.0001 |
| 122 |
DISSEMINATED INTRAVASCULAR COAGULATION |
1 |
0.0001 |
| 123 |
SKIN REACTION |
1 |
0.0001 |
| 124 |
CARDIOGENIC SHOCK |
1 |
0.0001 |
| 125 |
GASTROENTERITIS |
1 |
0.0001 |
| 126 |
ACUTE MYOCARDIAL INFARCTION |
2 |
0.0001 |
| 127 |
CARDIOMYOPATHY |
1 |
0.0001 |
| 128 |
URINARY INCONTINENCE |
2 |
0.0001 |
| 129 |
BLOOD POTASSIUM DECREASED |
2 |
0.0001 |
| 130 |
PHARYNGEAL OEDEMA |
1 |
0.0001 |
| 131 |
METASTASES TO BONE |
1 |
0.0001 |
| 132 |
VENTRICULAR TACHYCARDIA |
1 |
0.0001 |
| 133 |
GENERALISED TONIC-CLONIC SEIZURE |
1 |
0.0001 |
| 134 |
INFUSION RELATED REACTION |
4 |
0.0001 |
| 135 |
CIRCULATORY COLLAPSE |
1 |
0.0001 |
| 136 |
BLOOD TRIGLYCERIDES INCREASED |
1 |
0.0001 |
| 137 |
OSTEOMYELITIS |
1 |
0.0001 |
| 138 |
RESPIRATORY FAILURE |
4 |
0.0001 |
| 139 |
ACCIDENTAL OVERDOSE |
2 |
0.0001 |
| 140 |
RESTLESSNESS |
2 |
0.0001 |
| 141 |
HEPATIC FUNCTION ABNORMAL |
2 |
0.0001 |
| 142 |
MIDDLE INSOMNIA |
1 |
0.0001 |
| 143 |
BLOOD SODIUM DECREASED |
1 |
0.0001 |
| 144 |
HYPOCALCAEMIA |
1 |
0.0001 |
| 145 |
BLOOD PRESSURE SYSTOLIC INCREASED |
1 |
0.0001 |
| 146 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 147 |
FEEDING DISORDER |
1 |
0.0000 |
| 148 |
NEUTROPHIL COUNT DECREASED |
2 |
0.0000 |
| 149 |
PERITONITIS |
1 |
0.0000 |
| 150 |
PULMONARY HYPERTENSION |
1 |
0.0000 |
| 151 |
RHABDOMYOLYSIS |
2 |
0.0000 |
| 152 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 153 |
NO ADVERSE EVENT |
8 |
0.0000 |
| 154 |
HYPOKALAEMIA |
2 |
0.0000 |
| 155 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
1 |
0.0000 |
| 156 |
PRODUCT PRESCRIBING ERROR |
1 |
0.0000 |
| 157 |
ENCEPHALOPATHY |
1 |
0.0000 |
| 158 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 159 |
PNEUMONIA ASPIRATION |
1 |
0.0000 |
| 160 |
GASTRIC CANCER |
1 |
0.0000 |
| 161 |
BRADYCARDIA |
2 |
0.0000 |
| 162 |
CARDIAC FAILURE |
3 |
0.0000 |
| 163 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 164 |
PALLOR |
1 |
0.0000 |
| 165 |
CARDIAC ARREST |
3 |
0.0000 |
| 166 |
RESPIRATORY ARREST |
1 |
0.0000 |
| 167 |
DIVERTICULITIS |
1 |
0.0000 |
| 168 |
FEELING COLD |
1 |
0.0000 |
| 169 |
CONVULSION |
2 |
0.0000 |
| 170 |
ANGINA PECTORIS |
1 |
0.0000 |
| 171 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 172 |
CORONARY ARTERY DISEASE |
1 |
0.0000 |
| 173 |
PLEURAL EFFUSION |
2 |
0.0000 |
| 174 |
SWOLLEN TONGUE |
1 |
0.0000 |
| 175 |
METABOLIC ACIDOSIS |
1 |
0.0000 |
| 176 |
LACTIC ACIDOSIS |
1 |
0.0000 |
| 177 |
IMPAIRED HEALING |
1 |
0.0000 |
| 178 |
FEBRILE NEUTROPENIA |
2 |
0.0000 |
| 179 |
LIP SWELLING |
1 |
0.0000 |
| 180 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
0.0000 |
| 181 |
HYPOXIA |
1 |
0.0000 |
| 182 |
PLATELET COUNT DECREASED |
3 |
0.0000 |
| 183 |
CRYING |
1 |
0.0000 |
| 184 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 185 |
GENERAL PHYSICAL HEALTH DETERIORATION |
3 |
0.0000 |
| 186 |
PLASMA CELL MYELOMA |
1 |
0.0000 |
| 187 |
TREMOR |
4 |
0.0000 |
| 188 |
ROAD TRAFFIC ACCIDENT |
1 |
0.0000 |
| 189 |
TACHYCARDIA |
2 |
0.0000 |
| 190 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 191 |
ADVERSE EVENT |
2 |
0.0000 |
| 192 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 193 |
ARRHYTHMIA |
1 |
0.0000 |
| 194 |
OCULAR HYPERAEMIA |
1 |
0.0000 |
| 195 |
PULMONARY EMBOLISM |
2 |
0.0000 |
| 196 |
MIGRAINE |
2 |
0.0000 |
| 197 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 198 |
BLOOD GLUCOSE DECREASED |
1 |
0.0000 |
| 199 |
HYPOGLYCAEMIA |
1 |
0.0000 |
| 200 |
LUNG DISORDER |
1 |
0.0000 |
| 201 |
LEUKOPENIA |
1 |
0.0000 |
| 202 |
SYNCOPE |
2 |
0.0000 |
| 203 |
FLUSHING |
2 |
0.0000 |
| 204 |
CHEST DISCOMFORT |
2 |
0.0000 |
| 205 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 206 |
DRUG EFFECT DECREASED |
1 |
0.0000 |
| 207 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 208 |
WHITE BLOOD CELL COUNT DECREASED |
2 |
0.0000 |
| 209 |
TREATMENT NONCOMPLIANCE |
1 |
0.0000 |
| 210 |
SEPSIS |
2 |
0.0000 |
| 211 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 212 |
LETHARGY |
1 |
0.0000 |
| 213 |
CHILLS |
2 |
0.0000 |
| 214 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 215 |
HYPERSENSITIVITY |
3 |
0.0000 |
| 216 |
INJECTION SITE ERYTHEMA |
2 |
0.0000 |
| 217 |
SWELLING FACE |
1 |
0.0000 |
| 218 |
RENAL FAILURE |
2 |
0.0000 |
| 219 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 220 |
DEHYDRATION |
2 |
0.0000 |
| 221 |
NEOPLASM MALIGNANT |
1 |
0.0000 |
| 222 |
HYPOTENSION |
3 |
0.0000 |
| 223 |
PRODUCT QUALITY ISSUE |
2 |
0.0000 |
| 224 |
INFECTION |
2 |
0.0000 |
| 225 |
AGITATION |
1 |
0.0000 |
| 226 |
ABDOMINAL PAIN |
3 |
0.0000 |
| 227 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 228 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 229 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 230 |
MALAISE |
5 |
0.0000 |
| 231 |
DEVICE ISSUE |
1 |
0.0000 |
| 232 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 233 |
MUSCLE SPASMS |
2 |
0.0000 |
| 234 |
CHEST PAIN |
2 |
0.0000 |
| 235 |
CARDIAC DISORDER |
1 |
0.0000 |
| 236 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 237 |
CONTUSION |
1 |
0.0000 |
| 238 |
HEART RATE INCREASED |
1 |
0.0000 |
| 239 |
DIZZINESS |
5 |
0.0000 |
| 240 |
MALIGNANT NEOPLASM PROGRESSION |
1 |
0.0000 |
| 241 |
ERYTHEMA |
2 |
0.0000 |
| 242 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 243 |
HAEMORRHAGE |
1 |
0.0000 |
| 244 |
PNEUMONIA |
3 |
0.0000 |
| 245 |
CONSTIPATION |
2 |
0.0000 |
| 246 |
DYSPNOEA |
5 |
0.0000 |
| 247 |
SEIZURE |
1 |
0.0000 |
| 248 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 249 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 250 |
ANXIETY |
2 |
0.0000 |
| 251 |
RASH |
3 |
0.0000 |
| 252 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 253 |
HOSPITALISATION |
1 |
0.0000 |
| 254 |
VOMITING |
3 |
0.0000 |
| 255 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 256 |
PYREXIA |
2 |
0.0000 |
| 257 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 258 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 259 |
ANAEMIA |
1 |
0.0000 |
| 260 |
PRURITUS |
2 |
0.0000 |
| 261 |
ALOPECIA |
1 |
0.0000 |
| 262 |
NAUSEA |
4 |
0.0000 |
| 263 |
SOMNOLENCE |
1 |
0.0000 |
| 264 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 265 |
HYPERTENSION |
1 |
0.0000 |
| 266 |
WEIGHT INCREASED |
1 |
0.0000 |
| 267 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 268 |
DECREASED APPETITE |
1 |
0.0000 |
| 269 |
BACK PAIN |
1 |
0.0000 |
| 270 |
FEELING ABNORMAL |
1 |
0.0000 |
| 271 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 272 |
INJECTION SITE PAIN |
1 |
0.0000 |
| 273 |
DIARRHOEA |
2 |
0.0000 |
| 274 |
ASTHENIA |
1 |
0.0000 |
| 275 |
PAIN |
1 |
0.0000 |
| 276 |
HEADACHE |
1 |
0.0000 |
| 277 |
DRUG INEFFECTIVE |
2 |
0.0000 |
| 278 |
FATIGUE |
1 |
0.0000 |
| 279 |
DEATH |
1 |
0.0000 |
| 280 |
OFF LABEL USE |
1 |
0.0000 |